Delivery Order SPE2DB24D2013-SPE2DB25FCHHC

Award Date 1/31/25
Potential Completion Date 2/3/25
Potential Value $20K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,493.27 firm fixed-price delivery order is for the supply of LAMICTAL XR 200 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of January 30, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $18,263.43 firm fixed-price delivery order contract is for the supply of LAMICTAL XR 200 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of December 3, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract has an award value of $11,433.96 and is a Firm Fixed Price Delivery Order type contract with a completion date of July 18, 2024. The contract is for the supply of LAMICTAL XR 50 MG TABLET 30S, a pharmaceutical product. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a Delivery Order valued at $12,327.66 under an Indefinite Delivery Contract (IDC) with the Defense Logistics Agency (DLA) Troop Support Medical. The award, which has an ultimate completion date of October 23, 2024, is for the supply of LAMICTAL XR 300 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price arrangement and does not have a set-aside designation, indicating open...
This federal contract award, valued at $5,259.97, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of February 21, 2025. The contract covers the procurement of LAMICTAL XR 300 MG TABLET 30S, a pharmaceutical product used in the treatment of various medical conditions. Amerisourcebergen...
This is a federal contract award from the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,926.54 firm fixed-price delivery order is for LAMICTAL XR 300 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of June 12, 2024. AmerisourceBergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $5,668.16, is for the delivery of LAMICTAL XR 25 MG TABLET 30S, a pharmaceutical product. The contract is a Firm Fixed Price Delivery Order, with a period of performance through June 24, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,549.68 firm fixed-price delivery order is for the supply of LAMICTAL 100 MG TABLET 100S, a pharmaceutical product. The contract has an ultimate completion date of February 24, 2025 and was awarded on February 21, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $19,863.24 firm fixed-price delivery order contract is for the supply of LAMICTAL XR 25 MG TABLET 30S, a pharmaceutical product. The contract has an ultimate completion date of February 6, 2025. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,402.14 firm fixed-price delivery order is for the supply of LAMICTAL XR 100 MG TABLET 30S, a prescription medication. The contract has an ultimate completion date of December 21, 2023 and was awarded on December 20, 2023. There is no set-aside designation noted. AmerisourceBergen holds a $999,999,999 Indefinite...
  • SPE2DB24D2013
    Indefinite Delivery Contract
  • SPE2DB24D2013-SPE2DB25FCHHC
    Delivery Order

This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,322.49, is a Firm Fixed Price Delivery Order for the supply of LAMICTAL XR 200 MG TABLET 30S. The contract has an ultimate completion date of February 3, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies, serving the healthcare needs of military personnel, veterans, and other federal beneficiaries.

The contract award does not indicate any set-aside designation, suggesting open competition.

Generated 5/21/25, 10:36 AM